NVCR Stock Price History and Quote Analysis: Insights for Investors
NovoCure Limited
Stock Price Today
NovoCure Limited (NVCR) stock surged +1.62%, trading at $16.32 on NASDAQ, up from the previous close of $16.06. The stock opened at $16.06, fluctuating between $15.91 and $16.48 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Company Information
| Employees | 1453 |
| Beta | 0.71 |
| Sales or Revenue | $509.34M |
| 5Y Sales Change% | 0.772% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
Frequently Asked Questions
NovoCure Limited (NASDAQ: NVCR) stock price is $16.32 in the last trading session. During the trading session, NVCR stock reached the peak price of $16.48 while $15.91 was the lowest point it dropped to. The percentage change in NVCR stock occurred in the recent session was 1.62% while the dollar amount for the price change in NVCR stock was $0.26.
The NASDAQ listed NVCR is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. NovoCure Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Moshe Giladi Ph.D.
Chief Science Officer
Mr. Asaf Danziger
Pres, Chief Executive Officer & Director
Ms. Ashley Cordova
Chief Financial Officer
Mr. Uri Weinberg M.D., Ph.D.
Chief Science Officer
Ms. Ingrid Goldberg
Vice President of Investor Relations
Mr. Pritesh Shah
Chief Growth Officer
Mr. William F. Doyle
Executive Chairman
Mr. Wilhelmus C. M. Groenhuysen
Chief Operating Officer
Mr. William Patrick Burke
Chief HR Officer
Mr. Barak Ben Arye
Gen. Counsel
Prof. Yoram Palti M.D., Ph.D.
Founder & Chief Technology Officer
Mr. Frank Leonard
Pres of CNS Cancers U.S.
NVCR's closing price is 47.75% higher than its 52-week low of $10.87 where as its distance from 52-week high of $24.74 is -35.07%.
Number of NVCR employees currently stands at 1,453.
Official Website of NVCR is: https://www.novocure.com
NVCR could be contacted at phone 441 534 756700 and can also be accessed through its website. NVCR operates from No. 4 The Forum, Saint Helier, JE2 4UF, Jersey.
NVCR stock volume for the day was 182.29K shares. The average number of NVCR shares traded daily for last 3 months was 995.84K.
The market value of NVCR currently stands at $1.77B with its latest stock price at $16.32 and 108.22M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com